BISOPROLOL ZENTIVA K.S 2.5 mg, tablet 90 tablets
Active ingredients: Bisoprolol monofumarate
Commercialized according to BDPMDispensing in France: Prescription only
Tablet90 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BISOPROLOL ZENTIVA K.S 2,5 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 90 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 9 Mar 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66997921CIP73022543CIP133400930225431Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FUMARATE DE BISOPROLOLcomprimé | 2,5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.